Search Results - Satoshi Yoshihara

  • Showing 1 - 10 results of 10
Refine Results
  1. 1
    Bronchiolitis Obliterans Syndrome (BOS), Bronchiolitis Obliterans Organizing Pneumonia (BOOP), and Other Late-Onset Noninfectious Pulmonary Complications following Allogeneic Hematopoietic Stem Cell Transplantation

    Bronchiolitis Obliterans Syndrome (BOS), Bronchiolitis Obliterans Organizing Pneumonia (BOOP), and Other Late-Onset Noninfectious Pulmonary Complications following Allogeneic Hemat... by Satoshi Yoshihara, Gregory A. Yanik, Kenneth R. Cooke, Shin Mineishi

    Published 2007
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Posttransplant Hemophagocytic Lymphohistiocytosis Driven by Myeloid Cytokines and Vicious Cycles of T-Cell and Macrophage Activation in Humanized Mice

    Posttransplant Hemophagocytic Lymphohistiocytosis Driven by Myeloid Cytokines and Vicious Cycles of T-Cell and Macrophage Activation in Humanized Mice by Satoshi Yoshihara, Yuying Li, Jinxing Xia, Nichole Danzl, Megan Sykes, Yong‐Guang Yang

    Published 2019
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Unmanipulated HLA 2–3 Antigen-Mismatched (Haploidentical) Stem Cell Transplantation Using Nonmyeloablative Conditioning

    Unmanipulated HLA 2–3 Antigen-Mismatched (Haploidentical) Stem Cell Transplantation Using Nonmyeloablative Conditioning by Hiroyasu Ogawa, Kazuhiro Ikegame, Satoshi Yoshihara, Manabu Kawakami, Tatsuya Fujioka, Tomoki Masuda, Yuki Taniguchi, Hitomi Hasei, Katsuji Kaida, Takayuki Inoue, Eui Ho Kim, Ichiro Kawase

    Published 2006
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Unmanipulated HLA 2-3 antigen–mismatched (haploidentical) bone marrow transplantation using only pharmacological GVHD prophylaxis

    Unmanipulated HLA 2-3 antigen–mismatched (haploidentical) bone marrow transplantation using only pharmacological GVHD prophylaxis by Hiroyasu Ogawa, Kazuhiro Ikegame, Katsuji Kaida, Satoshi Yoshihara, Tatsuya Fujioka, Yuki Taniguchi, Hiroya Tamaki, Takayuki Inoue, Hitomi Hasei, Yasuhiko Iiboshi, Yuko Tazuke, Manabu Kawakami, Eui Ho Kim, Toshihiro Soma, Takehiro Inoue, Ichiro Kawase

    Published 2007
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Unmanipulated Haploidentical Reduced-Intensity Stem Cell Transplantation Using Fludarabine, Busulfan, Low-Dose Antithymocyte Globulin, and Steroids for Patients in Non–Complete Remission or at High Risk of Relapse: A Prospective Multicenter Phase I/II Study in Japan

    Unmanipulated Haploidentical Reduced-Intensity Stem Cell Transplantation Using Fludarabine, Busulfan, Low-Dose Antithymocyte Globulin, and Steroids for Patients in Non–Complete Rem... by Kazuhiro Ikegame, Takashi Yoshida, Satoshi Yoshihara, Takashi Daimon, Hiroaki Shimizu, Yoshinobu Maeda, Yasunori Ueda, Katsuji Kaida, Shin‐ichi Ishii, Kyoko Taniguchi, Masaya Okada, Hiroya Tamaki, Hirokazu Okumura, Hiroyasu Kaya, Toshiro Kurokawa, Yoshihisa Kodera, Shuichi Taniguchi, Yoshinobu Kanda, Hiroyasu Ogawa

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Induction of <i>WT1</i> (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression

    Induction of <i>WT1</i> (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression by Yoshitaka Oka, Akihiro Tsuboi, Tetsuya Taguchi, Tadashi Osaki, Taiichi Kyo, Hiroko Nakajima, Olga A. Elisseeva, Yusuke Oji, Manabu Kawakami, Kazuhiro Ikegame, Naoki Hosen, Satoshi Yoshihara, Fei Wu, Fumihiro Fujiki, Masaki Murakami, Tomoki Masuda, Sumiyuki Nishida, Toshiaki Shirakata, Shin‐ichi Nakatsuka, Ayako Sasaki, Keiko Udaka, Hiroo Dohy, Katsuyuki Aozasa, Shinzaburo Noguchi, Ichiro Kawase, Haruo Sugiyama

    Published 2004
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Risk factors for <scp>CAR‐T</scp> cell manufacturing failure among <scp>DLBCL</scp> patients: A nationwide survey in Japan

    Risk factors for <scp>CAR‐T</scp> cell manufacturing failure among <scp>DLBCL</scp> patients: A nationwide survey in Japan by Tomoyasu Jo, Satoshi Yoshihara, Yoshiki Okuyama, Keiko Fujii, Tomoko Henzan, Kaoru Kahata, Rie Yamazaki, Wataru Takeda, Yoshihiro Umezawa, Kentaro Fukushima, Takashi Ashida, Minami Yamada‐Fujiwara, Ryo Hanajiri, Noboru Yonetani, Yuma Tada, Yuji Shimura, Hidekazu Nishikii, Norio Shiba, Naoya Mimura, Jun Ando, Takayuki Sato, Yasuhiro Nakashima, Junko Ikemoto, Keita Iwaki, Shin‐ichiro Fujiwara, Masaki Ri, Tokiko Nagamura‐Inoue, Ryuji Tanosaki, Yasuyuki Arai

    Published 2023
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Clonal evolution and clinical implications of genetic abnormalities in blastic transformation of chronic myeloid leukaemia

    Clonal evolution and clinical implications of genetic abnormalities in blastic transformation of chronic myeloid leukaemia by Yotaro Ochi, Kenichi Yoshida, Ying‐Jung Huang, Ming‐Chung Kuo, Yasuhito Nannya, Ko Sasaki, Kinuko Mitani, Noriko Hosoya, Nobuhiro Hiramoto, Takayuki Ishikawa, Susan Branford, Naranie Shanmuganathan, Kazuma Ohyashiki, Naoto Takahashi, Tomoiku Takaku, Shun Tsuchiya, Nobuhiro Kanemura, Nobuhiko Nakamura, Yasunori Ueda, Satoshi Yoshihara, Rabindranath Bera, Yusuke Shiozawa, Lanying Zhao, June Takeda, Yosaku Watatani, Rurika Okuda, Hideki Makishima, Yuichi Shiraishi, Kenichi Chiba, Hiroko Tanaka, Masashi Sanada, Akifumi Takaori‐Kondo, Satoru Miyano, Seishi Ogawa, Lee‐Yung Shih

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Final 3-year Results of the Dasatinib Discontinuation Trial in Patients With Chronic Myeloid Leukemia Who Received Dasatinib as a Second-line Treatment

    Final 3-year Results of the Dasatinib Discontinuation Trial in Patients With Chronic Myeloid Leukemia Who Received Dasatinib as a Second-line Treatment by Masaya Okada, Jun Imagawa, Hideo Tanaka, Hirohisa Nakamae, Masayuki Hino, Kazunori Murai, Yoji Ishida, Takashi Kumagai, Seiichi Sato, Kazuteru Ohashi, Hisashi Sakamaki, Hisashi Wakita, Nobuhiko Uoshima, Yasunori Nakagawa, Yosuke Minami, Masahiro Ogasawara, Tomoharu Takeoka, Hiroshi Akasaka, Takahiko Utsumi, Naokuni Uike, Tsutomu Sato, Sachiko Ando, Kensuke Usuki, S Mizuta, Satoshi Hashino, Tetsuhiko Nomura, Masato Shikami, H Fukutani, Yokiko Ohe, Hiroshi Kosugi, Hirohiko Shibayama, Yasuhiro Maeda, Toshihiro Fukushima, Hirohito Yamazaki, Kazuo Tsubaki, Toshimasa Kukita, Yoko Adachi, Toshiki Nataduka, Hiroto Sakoda, Hisayuki Yokoyama, Takahiro Okamoto, Yukari Shirasugi, Yasushi Onishi, Masaharu Nohgawa, Satoshi Yoshihara, Satoshi Morita, Junichi Sakamoto, Shinya Kimura

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Selective targeting of multiple myeloma cells with a monoclonal antibody recognizing the ubiquitous protein CD98 heavy chain

    Selective targeting of multiple myeloma cells with a monoclonal antibody recognizing the ubiquitous protein CD98 heavy chain by Kana Hasegawa, Shunya Ikeda, Moto Yaga, Kouki Watanabe, Rika Urakawa, Akie Iehara, Mai Iwai, Seishin Hashiguchi, Soyoko Morimoto, Fumihiro Fujiki, Hiroko Nakajima, Jun Nakata, Sumiyuki Nishida, Akihiro Tsuboi, Yoshitaka Oka, Satoshi Yoshihara, Masahiro Manabe, Hiroyoshi Ichihara, Atsuko Mugitani, Yasutaka Aoyama, Takafumi Nakao, Asao Hirose, Masayuki Hino, Shiho Ueda, Katsuto Takenaka, Takashi Masuko, Koichi Akashi, Takahiro Maruno, Susumu Uchiyama, Shinji Takamatsu, Naoki Wada, Eiichi Morii, Shushi Nagamori, Daisuke Motooka, Yoshikatsu Kanai, Yusuke Oji, Tomoyoshi Nakagawa, Noriyuki Kijima, Haruhiko Kishima, Atsuyo Ikeda, Takayuki Ogino, Yasushi Shintani, Tateki Kubo, Emiko Mihara, Kosuke Yusa, Haruo Sugiyama, Junichi Takagi, Eiji Miyoshi, Atsushi Kumanogoh, Naoki Hosen

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: